REKA logo

Rekah Pharmaceutical Industry Ltd. Stock Price

TASE:REKA Community·₪141.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

REKA Share Price Performance

₪12.36
-1.97 (-13.75%)
₪12.36
-1.97 (-13.75%)
Price ₪12.36

REKA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
1 Reward

Rekah Pharmaceutical Industry Ltd. Key Details

₪300.2m

Revenue

₪227.6m

Cost of Revenue

₪72.7m

Gross Profit

₪86.8m

Other Expenses

-₪14.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.24
24.21%
-4.70%
63.8%
View Full Analysis

About REKA

Founded
1947
Employees
421
CEO
Mordechai Elgrabli
WebsiteView website
www.rekah.co.il

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. Rekah Pharmaceutical Industry Ltd. was founded in 1947 and is based in Holon, Israel.

Recent REKA News & Updates

Little Excitement Around Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Revenues

Jan 24
Little Excitement Around Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Revenues

Recent updates

No updates